KMDA Stock: Kamada Ltd. Stock Price, Analysis & Insights
Get live KMDA stock price $7.29, comprehensive Kamada Ltd. stock analysis, charts, news, and expert forecast. Real-time KMDA stock data and investment insights.
Loading chart data...
Kamada Ltd. (KMDA) Overview
Kamada Ltd. (KMDA) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, KMDA trades at $7.29 with a market capitalization of 420.82M . Over the past 52 weeks, KMDA has traded between $6.50 and $9.35 , with the current price positioned at approximately 28% of this range . The stock cu...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
- Market cap: 420.82M
- Current price: $7.29
- 52-week range: $6.50 - $9.35
- P/E ratio: 20.84
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Kamada Ltd. is a biopharmaceutical firm focused on developing, manufacturing, and distributing protein therapeutics derived from human plasma. The company operates through two core business areas: its proprietary product segment and its distribution ...
Company Information
- CEO
- Amir London
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 420
Contact Information
- Website
- https://www.kamada.com
- Address
- 2 Holzman Street
- Country
- IL
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 20.8)
✓ Lower volatility stock (Beta: 0.15) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Kamada Ltd. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Kamada Ltd.
- ⚠Investors should consider how Kamada Ltd. fits within their overall portfolio allocation
Market Cap
420.82M
P/E Ratio (TTM)
20.84
Beta
0.15
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare KMDA with peer companies:
- Price
- $4.82
- Market cap
- 356.79M
- Price
- $6.81
- Market cap
- 448.14M
- Price
- $2.36
- Market cap
- 155.09M
- Price
- $17.42
- Market cap
- 424.07M
- Price
- $0.97
- Market cap
- 191.89M
- Price
- $2.63
- Market cap
- 286.63M
- Price
- $6.57
- Market cap
- 511.87M
- Price
- $20.33
- Market cap
- 310.75M
- Price
- $26.55
- Market cap
- 598.87M
- Price
- $41.91
- Market cap
- 525.53M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.